MORANDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.327
EU - Europa 3.168
AS - Asia 2.345
SA - Sud America 333
AF - Africa 61
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.253
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.281
PL - Polonia 1.044
RU - Federazione Russa 890
SG - Singapore 709
CN - Cina 618
IT - Italia 478
HK - Hong Kong 334
BR - Brasile 258
VN - Vietnam 247
KR - Corea 177
IE - Irlanda 156
SE - Svezia 143
FR - Francia 100
FI - Finlandia 99
DE - Germania 76
IN - India 47
GB - Regno Unito 45
BD - Bangladesh 40
ID - Indonesia 39
ES - Italia 37
NL - Olanda 32
JO - Giordania 28
AR - Argentina 27
CA - Canada 20
EC - Ecuador 19
UA - Ucraina 18
AU - Australia 17
JP - Giappone 16
CH - Svizzera 14
IQ - Iraq 14
TR - Turchia 14
ZA - Sudafrica 14
MX - Messico 13
BE - Belgio 11
CI - Costa d'Avorio 11
AE - Emirati Arabi Uniti 10
PK - Pakistan 9
CO - Colombia 8
NG - Nigeria 8
MA - Marocco 7
TW - Taiwan 7
CL - Cile 6
MY - Malesia 6
AT - Austria 5
AZ - Azerbaigian 5
GR - Grecia 5
UY - Uruguay 5
BJ - Benin 4
DZ - Algeria 4
EG - Egitto 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AL - Albania 3
IL - Israele 3
KE - Kenya 3
PA - Panama 3
SA - Arabia Saudita 3
BG - Bulgaria 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AO - Angola 1
BO - Bolivia 1
CY - Cipro 1
EU - Europa 1
GL - Groenlandia 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
KI - Kiribati 1
LT - Lituania 1
LV - Lettonia 1
MM - Myanmar 1
NI - Nicaragua 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
ZW - Zimbabwe 1
Totale 10.253
Salva come PNG Salva come JPEG
Città #
Warsaw 1.040
Santa Clara 843
Ashburn 585
Singapore 545
Fairfield 453
Hong Kong 295
Woodbridge 198
San Jose 192
Seattle 188
Houston 186
Seoul 170
Cambridge 164
Dublin 156
Florence 138
Hefei 138
Chandler 134
Wilmington 129
Beijing 125
Ann Arbor 90
Ho Chi Minh City 83
Altamura 69
Lawrence 69
Helsinki 65
Council Bluffs 56
Los Angeles 50
Lauterbourg 49
Buffalo 46
Hanoi 44
Princeton 43
The Dalles 42
São Paulo 35
Jakarta 34
Moscow 32
Shanghai 31
Medford 30
New York 28
Paris 28
Dong Ket 27
Clifton 26
San Diego 26
Kent 25
Mumbai 23
Munich 23
Dallas 22
Boston 20
Frankfurt am Main 20
Barcelona 18
Melbourne 17
Milan 16
Phoenix 16
Tokyo 15
Da Nang 13
Lappeenranta 13
London 13
Orem 13
Bern 12
Boardman 12
Falls Church 12
Abidjan 11
Brussels 11
Naples 11
Rome 11
Tianjin 11
Brooklyn 10
Chicago 10
Belo Horizonte 9
Jacksonville 9
Redondo Beach 9
Yubileyny 9
Amman 8
Brasília 8
Chieri 8
Hangzhou 8
Turku 8
Abuja 7
Baghdad 7
Bengaluru 7
Guangzhou 7
Johannesburg 7
Quito 7
Stockholm 7
Turin 7
Can Tho 6
Denver 6
Donostia / San Sebastian 6
Guayaquil 6
Hải Dương 6
Istanbul 6
Nuremberg 6
Padua 6
Ribeirão Preto 6
San Francisco 6
Amsterdam 5
Baku 5
Haiphong 5
Qingdao 5
Redmond 5
Rio de Janeiro 5
Andover 4
Biên Hòa 4
Totale 7.290
Salva come PNG Salva come JPEG
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 369
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 358
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 335
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. 329
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 311
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 284
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 271
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread 259
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib 249
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer 246
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 245
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts 221
Lactate modulates CD4 + T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis 212
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival 211
Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance 206
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 206
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. 203
Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy 201
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 194
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors 192
Senescent stroma promotes prostate cancer progression: The role of miR-210 186
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer 184
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 179
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer 178
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 174
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 174
Signaling pathways regulating redox balance in cancer metabolism 174
Linking metabolic reprogramming to therapy resistance in cancer 172
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 170
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 164
Lactate: A Metabolic Driver in the Tumour Landscape 164
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer 163
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 158
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 156
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 155
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism 154
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 153
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors 153
Metabolic implication of tumor:stroma crosstalk in breast cancer. 152
Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer 152
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 148
RET in breast cancer: functional and therapeutic implications 147
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk 144
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 143
Targeting RET-interleukin-6 crosstalk to impair metastatic dissemination in breast cancer 142
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 128
A novel phage display based platform for exosome diversity characterization 125
In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer 119
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers 112
CD44 and SLC1A2 are commonly regulated but do not form a fusion transcript in ER+ breast cancer 110
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase 108
Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance 100
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 90
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease 80
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 72
Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinoma 45
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes 43
ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer 42
MAPK15 controls intracellular lipid uptake and protects mammalian liver from steatotic disease 33
Sub-lethal concentrations of Aβ oligomers and glutamate induce ROS formation largely by calcium-mediated activation of the NADPH oxidase 18
Totale 10.366
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.099
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 0 0 0 0 0 48 48
2021/2022396 13 69 36 14 20 11 20 42 11 32 40 88
2022/2023778 62 190 44 41 49 137 96 35 69 9 27 19
2023/2024402 16 35 49 15 31 23 20 102 28 22 31 30
2024/20252.606 84 234 153 383 695 365 64 191 111 76 100 150
2025/20263.370 343 446 354 359 450 131 474 184 201 262 166 0
Totale 10.366